High-throughput structure determination of an intrinsically disordered protein using cell-free protein crystallization.


Journal

Proceedings of the National Academy of Sciences of the United States of America
ISSN: 1091-6490
Titre abrégé: Proc Natl Acad Sci U S A
Pays: United States
ID NLM: 7505876

Informations de publication

Date de publication:
18 Jun 2024
Historique:
medline: 11 6 2024
pubmed: 11 6 2024
entrez: 11 6 2024
Statut: ppublish

Résumé

Intrinsically disordered proteins (IDPs) play a crucial role in various biological phenomena, dynamically changing their conformations in response to external environmental cues. To gain a deeper understanding of these proteins, it is essential to identify the determinants that fix their structures at the atomic level. Here, we developed a pipeline for rapid crystal structure analysis of IDP using a cell-free protein crystallization (CFPC) method. Through this approach, we successfully demonstrated the determination of the structure of an IDP to uncover the key determinants that stabilize its conformation. Specifically, we focused on the 11-residue fragment of c-Myc, which forms an α-helix through dimerization with a binding partner protein. This fragment was strategically recombined with an in-cell crystallizing protein and was expressed in a cell-free system. The resulting crystal structures of the c-Myc fragment were successfully determined at a resolution of 1.92 Å and we confirmed that they are identical to the structures of the complex with the native binding partner protein. This indicates that the environment of the scaffold crystal can fix the structure of c-Myc. Significantly, these crystals were obtained directly from a small reaction mixture (30 µL) incubated for only 72 h. Analysis of eight crystal structures derived from 22 mutants revealed two hydrophobic residues as the key determinants responsible for stabilizing the α-helical structure. These findings underscore the power of our CFPC screening method as a valuable tool for determining the structures of challenging target proteins and elucidating the essential molecular interactions that govern their stability.

Identifiants

pubmed: 38861600
doi: 10.1073/pnas.2322452121
doi:

Substances chimiques

Intrinsically Disordered Proteins 0
Proto-Oncogene Proteins c-myc 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2322452121

Subventions

Organisme : MEXT | Japan Society for the Promotion of Science (JSPS)
ID : JP19H02830 JP20K21244
Organisme : MEXT | JST | Adaptable and Seamless Technology Transfer Program through Target-Driven R and D (A-STEP)
ID : JPMJTR20U1
Organisme : MEXT | Japan Society for the Promotion of Science (JSPS)
ID : JP18K05140

Déclaration de conflit d'intérêts

Competing interests statement:The authors declare no competing interest.

Auteurs

Mariko Kojima (M)

School of Life Science and Technology, Tokyo Institute of Technology, Midori-ku, Yokohama 226-8501, Japan.

Satoshi Abe (S)

School of Life Science and Technology, Tokyo Institute of Technology, Midori-ku, Yokohama 226-8501, Japan.

Tadaomi Furuta (T)

School of Life Science and Technology, Tokyo Institute of Technology, Midori-ku, Yokohama 226-8501, Japan.

Kunio Hirata (K)

Synchrotron Radiation Life Science Instrumentation Unit, RIKEN/SPring-8 Center, Sayo-cho, Sayo-gun, Hyogo 679-5148, Japan.

Xinchen Yao (X)

School of Life Science and Technology, Tokyo Institute of Technology, Midori-ku, Yokohama 226-8501, Japan.

Ayako Kobayashi (A)

School of Life Science and Technology, Tokyo Institute of Technology, Midori-ku, Yokohama 226-8501, Japan.

Ririko Kobayashi (R)

School of Life Science and Technology, Tokyo Institute of Technology, Midori-ku, Yokohama 226-8501, Japan.

Takafumi Ueno (T)

School of Life Science and Technology, Tokyo Institute of Technology, Midori-ku, Yokohama 226-8501, Japan.
Research Center for Autonomous Systems Materialogy (ASMat), Institute of Innovative Research, Tokyo Institute of Technology, Midori-ku, Yokohama 226-8501, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH